<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><study_type>Cancer Genomics</study_type><full_dataset_link>https://ega-archive.org/studies/EGAS00001003760</full_dataset_link><host>EGA</host><description>EGA study EGAS00001003760</description><dataset_title>RNA-sequencing</dataset_title><dataset_title>Whole Exome Sequencing</dataset_title><category>restricted</category><repository>EGA</repository></additional><is_claimable>false</is_claimable><name>Genetics and transcriptomes of pediatric B cell precursor leukemia with gain of chromosome 21</name><description>Down syndrome (DS, constitutive trisomy 21) children have a 27-fold increased risk of developing B-ALL (DS-ALL), face a worse outcome due to treatment-related morbidities, and an increased rate of relapses compared to other children. This highlights the need to better understand the mechanisms of DS-associated leukemogenesis to develop more adapted treatment. In this study, we characterized the genetic and transcriptomic landscapes of DS-ALL and found a high incidence of somatic mutations leading to RAS/MAPK pathway activation in DS-ALL, as seen in other pediatric B-ALL presenting somatic gains of the chromosome 21 (B-ALL+21).</description><dates><updated>2022-02-21 13:14:33</updated></dates><accession>EGAS00001003760</accession><cross_references><TAXONOMY>9606</TAXONOMY><EGA>EGAD00001005425</EGA><EGA>EGAD00001005426</EGA><EGA>EGAC00001001348</EGA></cross_references></HashMap>